PORTOLA PHARMACEUTICALS INC's ticker is PTLA and the CUSIP is 737010108. A total of 172 filers reported holding PORTOLA PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is 0.45 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $111,000 | +98.2% | 2,935 | +70.1% | 0.90% | +164.7% |
| Q1 2018 | $56,000 | -33.3% | 1,725 | 0.0% | 0.34% | -35.6% |
| Q4 2017 | $84,000 | -46.2% | 1,725 | -40.1% | 0.53% | +85.3% |
| Q3 2017 | $156,000 | -3.7% | 2,880 | 0.0% | 0.28% | -7.2% |
| Q2 2017 | $162,000 | -16.1% | 2,880 | -41.5% | 0.31% | -21.5% |
| Q1 2017 | $193,000 | +0.5% | 4,925 | +31.7% | 0.39% | +237.1% |
| Q4 2015 | $192,000 | – | 3,740 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Grace Capital | 270,832 | $6,467,000 | 5.27% |
| Fernwood Investment Management, LLC | 336,111 | $8,026,000 | 3.84% |
| Tamarack Advisers, LP | 595,000 | $14,268,000 | 3.26% |
| First Light Asset Management, LLC | 1,008,957 | $24,094,000 | 3.08% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 1,540,679 | $36,791,000 | 2.79% |
| CADIAN CAPITAL MANAGEMENT, LP | 2,133,343 | $50,944,000 | 2.25% |
| SECTORAL ASSET MANAGEMENT INC | 606,189 | $14,476,000 | 2.16% |
| Asymmetry Capital Management, L.P. | 49,431 | $1,180,000 | 2.12% |
| Parkman Healthcare Partners LLC | 275,505 | $6,579,000 | 1.90% |
| HARVEY CAPITAL MANAGEMENT INC | 150,751 | $3,599,000 | 1.60% |